Sention Technologies

Sention Technologies

Advanced diagnostic solutions optimizing cell performance, reducing costs, and enhancing safety through ultrasound and machine learning. Learn more

Launch date
Employees
Market cap
-
Enterprise valuation
€2—4m (Dealroom.co estimates Jan 2023.)
London England (HQ)
  • Edit
DateInvestorsAmountRound

N/A

Spinout
*

£500k

Seed
*

£170k

Grant
Total Funding€804k

Recent News about Sention Technologies

Edit
More about Sention Technologiesinfo icon
Edit

Sention.io is a pioneering company specializing in advanced diagnostic techniques and machine learning to optimize cell performance at any stage of its life. Operating in the biotechnology and healthcare sectors, Sention.io serves clients ranging from research institutions to pharmaceutical companies. The company's proprietary approaches include ultrasound imaging, X-ray computed tomography, thermal analysis, and electrochemical characterization. These technologies allow for the detailed examination of critical chemical, structural, and physical properties that determine cell performance, quality, and safety. Sention.io's business model revolves around providing diagnostic services and selling proprietary diagnostic equipment. Revenue is generated through service contracts, equipment sales, and potentially licensing its technology to other firms. The company aims to reduce costs and improve safety for its clients by offering precise and reliable diagnostic solutions.

Keywords: diagnostic techniques, machine learning, ultrasound imaging, X-ray tomography, thermal analysis, electrochemical characterization, cell performance, biotechnology, healthcare, proprietary technology, cost reduction.